Heart Disease Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Heart Disease Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Heart Disease
Studies from Linkoping University update current data on heart disease
July 6th, 2008
"Evidence suggests that an early interventional strategy for patients with non-ST-elevation acute coronary syndrome (NSTE-ACS) can improve health outcomes but also increase costs when compared with a conservative strategy. The aim of this study was to assess the cost-effectiveness of an early interventional strategy in different risk groups from a UK health-service perspective," researchers in Sweden report. "Decision-analytic model based on randomised clinical trial data. Costs in UK Sterling at 2003/2004 prices and quality-adjusted life years (QALYs) combined into an incremental cost-effectiveness ratio. Data from the third Randomised Intervention Trial of unstable...
Source: Heart Disease Weekly (2008-07-06)
|
